| Quantitative characterization of 3D bioprinted structural elements under cell generated forces CD Morley, ST Ellison, T Bhattacharjee, CS O’Bryan, Y Zhang, KF Smith, ... Nature communications 10 (1), 3029, 2019 | 94 | 2019 |
| Personalized tumor RNA loaded lipid-nanoparticles prime the systemic and intratumoral milieu for response to cancer immunotherapy EJ Sayour, A Grippin, G De Leon, B Stover, M Rahman, A Karachi, ... Nano letters 18 (10), 6195-6206, 2018 | 71 | 2018 |
| Lin−CCR2+ hematopoietic stem and progenitor cells overcome resistance to PD-1 blockade CT Flores, TJ Wildes, JA Drake, GL Moore, BDV Dean, RS Abraham, ... Nature communications 9 (1), 4313, 2018 | 47 | 2018 |
| Immune escape after adoptive T-cell therapy for malignant gliomas TJ Wildes, KA Dyson, C Francis, B Wummer, C Yang, O Yegorov, D Shin, ... Clinical Cancer Research 26 (21), 5689-5700, 2020 | 34 | 2020 |
| Massive clonal expansion of medulloblastoma-specific T cells during adoptive cellular therapy C Flores, T Wildes, BDV Dean, G Moore, J Drake, R Abraham, J Gil, ... Science advances 5 (11), eaav9879, 2019 | 22 | 2019 |
| Establishing Developmental Genetics in a Self-fertilizing Fish (Krytolebias marmoratus) GL Moore, S Sucar, JM Newsome, ME Ard, L Bernhardt, MJ Bland, ... Integrative and comparative biology 52 (6), 781-791, 2012 | 16 | 2012 |
| Spatiotemporal T cell dynamics in a 3D bioprinted immunotherapy model CD Morley, CT Flores, JA Drake, GL Moore, DA Mitchell, TE Angelini Bioprinting 28, e00231, 2022 | 9 | 2022 |
| A Simultaneous Genetic Screen for Zygotic and Sterile Mutants in a Hermaphroditic Vertebrate (Kryptolebias marmoratus) S Sucar, GL Moore, ME Ard, BC Ring G3: Genes, Genomes, Genetics 6 (4), 1107-1119, 2016 | 7 | 2016 |
| mRNA-based precision targeting of neoantigens and tumor-associated antigens in malignant brain tumors V Trivedi, C Yang, K Klippel, O Yegorov, C von Roemeling, L Hoang-Minh, ... Genome Medicine 16 (1), 17, 2024 | 4 | 2024 |
| Immunotherapy reverses glioma-driven dysfunction of immune system homeostasis BDV Dean, T Wildes, J Dean, O Yegorov, C Yang, D Shin, C Francis, ... Journal for Immunotherapy of Cancer 11 (2), 2023 | 2 | 2023 |
| THE HYDROGEL-CXCL9-MRNA (HCM) VACCINE RESULTS IN SIGNIFICANT ANTI-TUMOR EFFICACY THROUGH RECRUITMENT OF NATURAL KILLER (NK) CELLS F Dastmalchi, N Thomas, G Ebrahim, M Frain, G Moore, ... Neuro-Oncology 24, 105-105, 2022 | 1 | 2022 |
| Tracking Dendritic Cell Vaccination Using Magnetic Particle Imaging B Yu, G Moore, A Armstrong, S Liu, AV Albino, DA Mitchell, ... 2023 AIChE Annual Meeting, 2023 | | 2023 |
| IMMU-36. PD-1KO HEMATOPOIETIC STEM CELLS RAPIDLY DIFFERENTIATE INTO GLIOMA-INFILTRATING EFFECTOR T-CELLS C Francis, BDV Dean, LF Font, J Figg, K Long-James, A Reid, D Jin, ... Neuro-Oncology 25 (Supplement_5), v150-v150, 2023 | | 2023 |
| PRECISION ANTIGEN-DIRECTED IMMUNOTHERAPY TREATMENT OF BRAIN TUMORS INCREASES TUMOR-INFILTRATING EFFECTOR LYMPHOCYTE RESPONSES V Trivedi, C Yang, O Yegorov, K Klippel, C Von Roemeling, ... NEURO-ONCOLOGY 25, 2023 | | 2023 |
| Development of personalized RNA-based immunotherapeutics for glioblastom V Trivedi, C Yang, O Yegorov, K Klippel, G Fenton, C von Roemeling, ... Cancer Research 83 (7_Supplement), 5114-5114, 2023 | | 2023 |
| EXTH-44. PERSONALIZED IMMUNOTHERAPY VACCINES FOR GLIOBLASTOMA AND THEIR TREATMENT EFFICACY V Trivedi, C Yang, G Fenton, O Yegorov, C Von Roemeling, K Klippel, ... Neuro-Oncology 24 (Supplement_7), vii219-vii219, 2022 | | 2022 |
| CCL4 DRIVES GLIOBLASTOMA (GBM) TUMOR MICROENVIRONMENT (TME) REPROGRAMMING AFTER TREATMENT WITH A NOVEL MRNA VACCINE F Dastmalchi, N Thomas, M Frain, G Ebrahim, G Moore, M Tomdio, ... NEURO-ONCOLOGY 24, 138-138, 2022 | | 2022 |
| IMMU-42. ADOPTIVE HEMATOPOIETIC STEM CELL AND APD1 THERAPY CONVERGE IN THE THYMUS TO PROMOTE ANTI-GLIOBLASTOMA IMMUNITY C Francis, LF Font, J Figg, BDV Dean, M Sebastian, D Jin, K Long-James, ... Neuro-Oncology 24 (Suppl 7), vii140, 2022 | | 2022 |
| SLOW CYCLING CELL RNA BASED T CELL THERAPY TO PREVENT RECURRENCE IN GBM M Dajac, C Conforti, G Tian, G Moore, C Flores, J Huang, D Mitchell, ... NEURO-ONCOLOGY 24, 36-36, 2022 | | 2022 |
| IMMU-50. GLIOBLASTOMA MANIPULATES HEMATOPOIETIC STEM CELL DIFFERENTIATION OUTCOMES AND DRIVES ALTERED IMMUNE RECONSTITUTION BDV Dean, T Wildes, J Dean, D Shin, C Francis, LF Font, G Moore, ... Neuro-oncology 23 (Supplement_6), vi104-vi104, 2021 | | 2021 |
Duane MitchellPhyllis Kottler Friedman Professor, University of Florida在 neurosurgery.ufl.edu 的电子邮件经过验证
